The Cost-Effectiveness of Olanzapine Treatment for Agitation and Psychosis in Alzheimer's Disease

被引:0
|
作者
Kirbaeh, Stephanie E. [1 ]
Simpson, Kit N. [2 ]
Nietert, Paul J. [2 ]
Mintzer, Jacobo E. [2 ]
机构
[1] Med Univ S Carolina, N Charleston, SC USA
[2] Med Univ S Carolina, Charleston, SC 29425 USA
来源
关键词
D O I
暂无
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
引用
收藏
页码:A71 / A72
页数:2
相关论文
共 50 条
  • [1] A Markov model of the cost effectiveness of olanzapine treatment for agitation and psychosis in Alzheimer's disease
    Kirbach, Stephanie
    Simpson, Kit
    Nietert, Paul J.
    Mintzer, Jacobo
    [J]. CLINICAL DRUG INVESTIGATION, 2008, 28 (05) : 291 - 303
  • [2] A Markov Model of the Cost Effectiveness of Olanzapine Treatment for Agitation and Psychosis in Alzheimer’s Disease
    Stephanie Kirbach
    Kit Simpson
    Paul J. Nietert
    Jacobo Mintzer
    [J]. Clinical Drug Investigation, 2008, 28 : 291 - 303
  • [3] Effectiveness and Cost-Effectiveness of the Pharmacological Treatment of Alzheimer's Disease and Vascular Dementia
    Versijpt, Jan
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2014, 42 : S19 - S25
  • [4] COST-EFFECTIVENESS OF DONEPEZIL IN THE TREATMENT OF PATIENTS WITH ALZHEIMER'S DISEASE: AN UPDATE
    Chyr, L. C.
    Yapici, H. O.
    Padula, W., V
    [J]. VALUE IN HEALTH, 2018, 21 : S206 - S206
  • [5] Cost-Effectiveness of Donepezil in the Treatment of Mild or Moderate Alzheimer's Disease
    Lopez-Bastida, Julio
    Hart, Warren
    Garcia-Perez, Lidia
    Linertova, Renata
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2009, 16 (02) : 399 - 407
  • [6] STRUCTURAL UNCERTAINTY IN COST-EFFECTIVENESS MODELS OF TREATMENT FOR ALZHEIMER'S DISEASE
    Peters, J. L.
    Hoyle, M.
    Anderson, R.
    [J]. VALUE IN HEALTH, 2010, 13 (07) : A240 - A240
  • [7] Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer's disease
    Neumann, PJ
    Hermann, RC
    Kuntz, KM
    Araki, SS
    Duff, SB
    Leon, J
    Berenbaum, PA
    Goldman, PA
    Williams, LW
    Weinstein, MC
    [J]. NEUROLOGY, 1999, 52 (06) : 1138 - 1145
  • [8] Emerging therapies for treatment of agitation, psychosis, or apathy in Alzheimer's disease
    Wang, Hui Jue
    Chinna-Meyyappan, Arun
    Feldman, Oriel J.
    Lanctot, Krista L.
    [J]. EXPERT OPINION ON EMERGING DRUGS, 2024, 29 (03) : 289 - 303
  • [9] The modern role of antipsychotics for the treatment of agitation and psychosis in Alzheimer's disease
    Creese, Byron
    Da Silva, Miguel Vasconcelos
    Johar, Iskandar
    Ballard, Clive
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2018, 18 (06) : 461 - 467
  • [10] Treatment of the agitation of late-life psychosis and Alzheimer's disease
    Salzman, C
    [J]. EUROPEAN PSYCHIATRY, 2001, 16 : 25S - 28S